top biopharmaceuticals for glp-1 medication Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch Prescription GLP-1s for Weight Loss

More indications are in advanced stages of clinical development, such as chronic spontaneous urticaria, unexplained chronic itching, pemphigoid, and ulcerative colitis

Compounded drug products are not approved or evaluated for safety, effectiveness, or quality by the FDA Compounded Semaglutide (GLP-1) Injections A once-weekly GLP-1 injection designed to help reduce appetite, improve metabolic health, and support sustainable weight loss under licensed medical supervision

We anticipate around seven actual launches in the US by 2030 after risk-adjustment

Amgen Inc

Higher obesity rates and a continually rising diabetes burden are generating meaningful demand for advanced care solutions

It was approved in Japan in July 2014 for the treatment of unresectable melanoma